Rachel Carlson

Yeah, some people definitely feel strongly that the whole experience that comes with these drugs is key when it comes to treating patients. Even David and Eliseo both told me they're not saying that we should replace psychedelics altogether with these non-hallucinogenic compounds. But they are saying that we should develop both things. Here's Eliseo.

Right. But again, not everyone feels like this is really the best way to approach the research. Remember Boris Heifetz? He's the anesthesiologist and neuroscientist at Stanford who did the ketamine study. We talked about it in our last episode. Yep. He and David are collaborators. And he told me that these new drugs, like the ones David's making, could be great.

Right. But again, not everyone feels like this is really the best way to approach the research. Remember Boris Heifetz? He's the anesthesiologist and neuroscientist at Stanford who did the ketamine study. We talked about it in our last episode. Yep. He and David are collaborators. And he told me that these new drugs, like the ones David's making, could be great.

Right. But again, not everyone feels like this is really the best way to approach the research. Remember Boris Heifetz? He's the anesthesiologist and neuroscientist at Stanford who did the ketamine study. We talked about it in our last episode. Yep. He and David are collaborators. And he told me that these new drugs, like the ones David's making, could be great.

But even then, if they do work, he still thinks these experiences people seem to have around psychedelics are really important. And for most patients, this whole idea of taking out the trip

But even then, if they do work, he still thinks these experiences people seem to have around psychedelics are really important. And for most patients, this whole idea of taking out the trip

But even then, if they do work, he still thinks these experiences people seem to have around psychedelics are really important. And for most patients, this whole idea of taking out the trip

And Gina, the thing that really sticks with me here as I've listened to scientists like have this conversation in their own research and with each other is that we're learning so much about the human brain right now. But there's also a ton that we don't know.

And Gina, the thing that really sticks with me here as I've listened to scientists like have this conversation in their own research and with each other is that we're learning so much about the human brain right now. But there's also a ton that we don't know.

And Gina, the thing that really sticks with me here as I've listened to scientists like have this conversation in their own research and with each other is that we're learning so much about the human brain right now. But there's also a ton that we don't know.

So I think this research in psychedelics is encouraging neuroscientists to confront how we study the brain at all, how we study our unique experiences differently. And where these two things, our chemical biological processes and our personal emotional ones, intersect.

So I think this research in psychedelics is encouraging neuroscientists to confront how we study the brain at all, how we study our unique experiences differently. And where these two things, our chemical biological processes and our personal emotional ones, intersect.

So I think this research in psychedelics is encouraging neuroscientists to confront how we study the brain at all, how we study our unique experiences differently. And where these two things, our chemical biological processes and our personal emotional ones, intersect.

So in our last episode, we talked about how drugs like psilocybin and ketamine are raising all these questions about the limits of what we know about our brains and how we experience reality.

So in our last episode, we talked about how drugs like psilocybin and ketamine are raising all these questions about the limits of what we know about our brains and how we experience reality.

So in our last episode, we talked about how drugs like psilocybin and ketamine are raising all these questions about the limits of what we know about our brains and how we experience reality.

Exactly. So when we're talking about how drugs like psychedelics and ketamine work, or if they work at all, what the heck are we actually talking about?

Exactly. So when we're talking about how drugs like psychedelics and ketamine work, or if they work at all, what the heck are we actually talking about?

Exactly. So when we're talking about how drugs like psychedelics and ketamine work, or if they work at all, what the heck are we actually talking about?

This is Dr. Boris Heifetz. He's an anesthesiologist and neuroscientist at Stanford University. And he told me that researchers have been wondering for a while if the trip that comes with a lot of psychedelics, this journey or experience, is really important, or if it's just this unnecessary byproduct when it comes to making people feel better.